☆ 4.7 Article

Myxopapillary Ependymoma With Pleuropulmonary Metastases and High Plasma Glial Fibrillary Acidic Protein Levels

JOURNAL OF CLINICAL ONCOLOGY (2011)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 29, Issue 30, Pages E756-E757

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1200/JCO.2011.36.6401

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Clinical Neurology

Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy

Shanice Beerepoot, Hans Heijst, Birthe Roos, Mirjam M. C. Wamelink, Jaap Jan Boelens, Caroline A. Lindemans, Peter M. van Hasselt, Edwin H. Jacobs, Marjo S. van der Knaap, Charlotte E. Teunissen, Nicole Wolf

Summary: This study compared neurofilament light chain and GFAP levels in patients with metachromatic leukodystrophy and healthy controls, suggesting that these two proteins may serve as biomarkers for clinical assessment and treatment decisions.

BRAIN (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Case 309: Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy

Paulo Puac-Polanco, Nader Zakhari, Gerard H. Jansen, Carlos Torres

Summary: A 64-year-old man presented with a 6-month history of lightheadedness and intermittent balance and coordination difficulties. He also experienced speech difficulties and cognitive changes. Initial MRI revealed abnormal findings in the left supratentorial brain.

RADIOLOGY (2023)

Add to Collection

Article Oncology

Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer

Amelie Darlix, Christophe Hirtz, Caroline Mollevi, Nelly Ginestet, Laurent Tiers, William Jacot, Sylvain Lehmann

Summary: In patients with metastatic breast cancer, elevated serum levels of GFAP are independently associated with the presence of brain metastases and poor outcomes, outperforming other biomarkers such as NfL, UCHL1, and tau. These findings suggest that GFAP may serve as a valuable diagnostic and prognostic factor for brain metastases in this patient population, although further validation in independent cohorts is necessary.

INTERNATIONAL JOURNAL OF CANCER (2021)

Add to Collection

Article Medicine, General & Internal

Changes in Plasma Glial Fibrillary Acidic Protein in Children Receiving Sevoflurane Anesthesia: A Preliminary Randomized Trial

Eun-Hee Kim, Young-Eun Jang, Sang-Hwan Ji, Ji-Hyun Lee, Sung-Ae Cho, Jin-Tae Kim, Hyunyee Yoon, Hee-Soo Kim

Summary: The study investigated changes in plasma glial fibrillary acidic protein concentration during sevoflurane anesthesia induction in children under 3 years old and found that three hours of anesthesia did not cause neuronal injury. However, co-administration of dexmedetomidine led to an increase in plasma glial fibrillary acidic protein levels after 180 minutes, indicating a potential effect on neuronal injury that requires further study.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder

Tian-Xiang Zhang, Jing-Shan Chen, Chen Du, Pei Zeng, Huiming Zhang, Xuejiao Wang, Ye Liu, Zhenning Huang, Meng Yuan, Yu-Lin Li, Dongmei Jia, Fu-Dong Shi, Chao Zhang

Summary: The study found that NMOSD patients had higher levels of plasma neurofilament light chain and plasma glial fibrillary acidic protein, which were related to age, disease severity, and recent relapses. Treatment with tocilizumab and rituximab significantly reduced these protein levels, indicating their potential as biomarkers for disease activity and treatment effects in NMOSD.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Clinical Neurology

Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures

Sarah Akel, Fredrik Asztely, Rakesh Kumar Banote, Markus Axelsson, Henrik Zetterberg, Johan Zelano

Summary: This study analyzed the levels of biochemical blood markers of brain injury in epilepsy patients and found that levels of neurofilament light, glial fibrillary acidic protein, and tau were correlated with age. Some patients showed evidence of brain injury.

EPILEPSIA (2023)

Add to Collection

Article Neurosciences

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

Nuole Zhu, Miguel Santos-Santos, Ignacio Illan-Gala, Victor Montal, Teresa Estelles, Isabel Barroeta, Miren Altuna, Javier Arranz, Laia Munoz, Olivia Belbin, Isabel Sala, Maria Belen Sanchez-Saudinos, Andrea Subirana, Laura Videla, Jordi Pegueroles, Rafael Blesa, Jordi Clarimon, Maria Carmona-Iragui, Juan Fortea, Alberto Lleo, Daniel Alcolea

Summary: This study found that plasma GFAP and plasma neurofilament light chain levels differ in frontotemporal dementia and Alzheimer's disease, and their combination is useful for distinguishing between the two diseases. In FTD patients, plasma GFAP is correlated with cognition, CSF and plasma NfL, and cortical thickness. Higher tertile of plasma GFAP is associated with greater cognitive decline during follow-up in FTD and AD patients.

TRANSLATIONAL NEURODEGENERATION (2021)

Add to Collection

Article Clinical Neurology

Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases

Xinqing Lin, Tingting Lu, Haiyi Deng, Chunxin Liu, Yilin Yang, Tao Chen, Yinyin Qin, Xiaohong Xie, Zhanhong Xie, Ming Liu, Ming Ouyang, Shiyue Li, Yong Song, Nanshan Zhong, Wei Qiu, Chengzhi Zhou

Summary: The study found that serum neurofilament light chain and glial fibrillary acidic protein could serve as potential diagnostic biomarkers for brain metastases in lung cancer patients. A diagnostic model was established to provide individual diagnoses, and higher levels of NfL were associated with poor prognosis in patients with brain metastases.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Chemistry, Analytical

Plasmon-enhanced near-infrared fluorescence detection of traumatic brain injury biomarker glial fibrillary acidic protein in blood plasma

Peng Zheng, Sujan Kasani, Weirui Tan, Jennifer Boryczka, Xuefei Gao, Feng Yang, Nianqiang Wu

Summary: An ultrasensitive plasmonic near-infrared fluorescent biosensor substrate has been developed for the detection of the important protein biomarker GFAP in traumatic brain injury. By using a near-infrared fluorophore and a plasmonic gold nanopyramid array, the biosensor achieves enhanced fluorescence signals and overcomes interference from the blood plasma matrix.

ANALYTICA CHIMICA ACTA (2022)

Add to Collection

Article Oncology

Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases

Su-Hyun Kim, Ho-Shin Gwak, Youngjoo Lee, Na-Young Park, Mira Han, Yeseul Kim, So-Yeon Kim, Ho Jin Kim

Summary: This study evaluated the roles of serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) in diagnosing and monitoring brain metastases. Both sNfL and sGFAP showed significant differences in levels between patients with and without BMs, and combining the two biomarkers improved sensitivity to up to 98%. The levels of sNfL and sGFAP were related to BM size and changed with BM progression and treatment, suggesting their potential as biomarkers for BM screening in cancer patients.

CANCERS (2021)

Add to Collection

Article Clinical Neurology

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis

Ahmed Abdelhak, Kai Antweiler, Markus C. Kowarik, Makbule Senel, Joachim Havla, Uwe K. Zettl, Ingo Kleiter, Thomas Skripuletz, Axel Haarmann, Alexander Stahmann, Andre Huss, Stefan Gingele, Markus Krumbholz, Pascal Benkert, Jens Kuhle, Tim Friede, Albert C. Ludolph, Ulf Ziemann, Tania Kuempfel, Hayrettin Tumani

Summary: This study confirms the value of serum GFAP and NfL in PPMS and SPMS, and indicates that the combination of high GFAP and low NfL levels can help identify progression risk in people with progressive multiple sclerosis.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

CD8+ T-cell predominance in autoimmune glial fibrillary acidic protein astrocytopathy

Zhongmin Yuan, Huilu Li, Lu Huang, Congcong Fu, Yaotang Chen, Cheng Zhi, Wei Qiu, Youming Long

Summary: In autoimmune GFAP astrocytopathy (GFAP-A), there is a predominance of CD8(+) T cells with marked lymphocytic infiltration, especially adjacent to dystrophic neurons and astrocytes. Additionally, there is diffuse infiltration by CD68(+) and CD163(+) macrophages. CD8(+) astrocytes were identified in some samples, but no CD4(+) astrocytes were observed.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study

Yingfang Liang, Gangqi Wang, Bixun Li, Guoliang Li, Hao Zeng

Summary: This study aimed to summarize the clinical features of Autoimmune Glial Fibrillary Acidic Protein Astrocytosis mimicking tuberculosis meningitis. The clinical manifestations, cerebrospinal fluid results, and imaging data of five patients were retrospectively analyzed. Anti-GFAP antibody testing should be routinely performed in patients with suspected tuberculosis meningitis to avoid misdiagnosis.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Critical Care Medicine

Plasma Neurofilament Light and Glial Fibrillary Acidic Protein Levels over Thirty Days in a Porcine Model of Traumatic Brain Injury

Samuel S. Shin, Marco M. Hefti, Vanessa M. Mazandi, David A. Issadore, David F. Meaney, Andrea L. C. Schneider, Ramon Diaz-Arrastia, Todd J. Kilbaugh

Summary: This study establishes the clinical relevance of a porcine model of traumatic brain injury by using diffusion tensor imaging and plasma biomarkers. It confirms the presence of long term white matter injury and suggests the need for further research on different types of brain injury.

JOURNAL OF NEUROTRAUMA (2022)

Add to Collection

Article Clinical Neurology

Glial Fibrillary Acidic Protein Levels in Post-Stroke Depression: A Prospective Ischemic Stroke Cohort

Wanying Shan, Jie Zhao, Chunfang Qiu, Guoli Xu, Jie Feng

Summary: Increased levels of GFAP in patients with ischemic stroke are associated with an increased risk of post-stroke depression. Measuring GFAP levels after ischemic stroke may provide some value in stratifying the risk of depression.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2023)

Add to Collection

Article Oncology

Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101

Emilie Le Rhun, Felix Boakye Oppong, Martin van den Bent, Wolfgang Wick, Alba A. Brandes, Martin J. B. Taphoorn, Michael Platten, Ahmed Idbaih, Paul M. Clement, Matthias Preusser, Vassilis Golfinopoulos, Thierry Gorlia, Michael Weller

Summary: This study retrospectively analyzed the incidence of lomustine-induced thrombocytopenia and its impact on treatment exposure and survival in patients with recurrent glioblastoma. The results showed that thrombocytopenia induced by lomustine is a major limitation to adequate exposure to lomustine chemotherapy and is associated with inferior progression-free survival, particularly in patients with MGMT promoter-methylated tumors.

EUROPEAN JOURNAL OF CANCER (2023)

Add to Collection

Review Oncology

Emerging systemic treatment options in meningioma

Maximilian J. Mair, Anna S. Berghoff, Priscilla K. Brastianos, Matthias Preusser

Summary: Meningiomas are the most frequently diagnosed intracranial neoplasms and surgical resection is the common treatment method. However, there is limited research on pharmacotherapy for meningiomas.

JOURNAL OF NEURO-ONCOLOGY (2023)

Add to Collection

Article Oncology

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection

David Capper, Guido Reifenberger, Pim J. French, Leonille Schweizer, Michael Weller, Mehdi Touat, Simone P. Niclou, Philipp Euskirchen, Christine Haberler, Monika E. Hegi, Sebastian Brandner, Emilie Le Rhun, Roberta Ruda, Marc Sanson, Ghazaleh Tabatabai, Felix Sahm, Patrick Y. Wen, Pieter Wesseling, Matthias Preusser, Martin J. van den Bent

Summary: The mainstay of treatment for adult patients with gliomas, glioneuronal and neuronal tumors consists of combinations of surgery, radiotherapy, and chemotherapy. For many systemic cancers, targeted treatments are a part of the standard of care, however, the predictive significance of most of these targets in central nervous system (CNS) tumors remains less well-studied.

NEURO-ONCOLOGY (2023)

Add to Collection

Editorial Material Oncology

Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana?

Matthias Preusser, Martin J. van den Bent

NEURO-ONCOLOGY (2023)

Add to Collection

Review Oncology

Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy

B. Fendl, A. S. Berghoff, M. Preusser, B. Maier

Summary: The introduction of immune checkpoint inhibitors (ICIs) has greatly changed the landscape of clinical routine for solid cancer treatment. However, many patients do not respond well to ICI treatment. Traditional immunotherapy approaches focus on stimulating anti-tumor T cell responses, but recent attention has shifted to tumor-associated macrophages as they play a crucial role in the tumor microenvironment. The polarization of tumor-associated macrophages is influenced by intensive cross-talk with various cells, which can either promote or inhibit tumorigenic activity. Further understanding of the molecular signals controlling macrophage polarization may lead to the development of new therapeutic approaches and potential combination therapies to improve efficacy.

ESMO OPEN (2023)

Add to Collection

Article Oncology

Brain metastases from hepatopancreatobiliary malignancies

Elisabeth S. Bergen, Alexander Friedrich, Peter Scherleitner, Pedro Ferreira, Barbara Kiesel, Georg Widhalm, Barbara Kiesewetter, Franziska Eckert, Gerald W. Prager, Matthias Preusser, Anna S. Berghoff

Summary: The prognosis of brain metastases from hepatopancreatobiliary tumors is very limited, with poor outcomes. Negative prognostic factors identified include performance status, age, and leptomeningeal carcinomatosis.

CLINICAL & EXPERIMENTAL METASTASIS (2023)

Add to Collection

Article Oncology

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer

Ladislaia Wolff, Ariane Steindl, Petar Popov, Karin Dieckmann, Brigitte Gatterbauer, Georg Widhalm, Anna Sophie Berghoff, Matthias Preusser, Markus Raderer, Barbara Kiesewetter

Summary: In this study, brain metastases (BM) in patients with thyroid cancer (TC) were found to be rare, with follicular and papillary thyroid carcinomas being the most common types. Most of the patients presented with symptomatic single lesions, and some patients were able to achieve long-term survival with local therapy.

CLINICAL & EXPERIMENTAL METASTASIS (2023)

Add to Collection

Article Oncology

Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer

Erwin Tomasich, Ariane Steindl, Christina Paiato, Teresa Hatziioannou, Markus Kleinberger, Luzia Berchtold, Rainer Puhr, Johannes A. Hainfellner, Leonhard Mullauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna Sophie Berghoff

Summary: This study investigated the expression of HER3 in brain metastases of breast cancer and non-small cell lung cancer, providing a basis for future clinical trial design. Results showed that HER3 is highly expressed in brain metastases of both cancer types, suggesting the need for specific trials targeting HER3 in brain metastases.

CLINICAL CANCER RESEARCH (2023)

Add to Collection

Article Oncology

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419)

Caroline Hertler, Joerg Felsberg, Dorothee Gramatzki, Emilie Le Rhun, Jennifer Clarke, Riccardo Soffietti, Wolfgang Wick, Olivier Chinot, Francois Ducray, Patrick Roth, Kerrie McDonald, Peter Hau, Andreas F. Hottinger, Jaap Reijneveld, Oliver Schnell, Christine Marosi, Michael Glantz, Amelie Darlix, Giuseppe Lombardi, Dietmar Krex, Martin Glas, David A. Reardon, Martin van den Bent, Florence Lefranc, Ulrich Herrlinger, Evangelia Razis, Antoine F. Carpentier, Samuel Phillips, Roberta Ruda, Antje Wick, Emeline Tabouret, David Meyronet, Claude-Alain Maurage, Elisabeth Rushing, Robert Rapkins, Elisabeth Bumes, Monika Hegi, Astrid Weyerbrock, Dawit Aregawi, Christian Gonzalez-Gomez, Alessia Pellerino, Martin Klein, Matthias Preusser, Martin Bendszus, Vassilis Golfinopoulos, Andreas von Deimling, Thierry Gorlia, Patrick Y. Wen, Guido Reifenberger, Michael Weller

Summary: This study analyzed patients with glioblastoma who survived at least 5 years and found that only a few patients can survive for longer periods. The characteristics and factors associated with long-term survival remain poorly defined.

EUROPEAN JOURNAL OF CANCER (2023)

Add to Collection

Article Clinical Neurology

The effect of perioperative non-steroidal anti-inflammatory drugs and male sex on the recurrence rates after chronic subdural hematoma evacuation

Matthias Tomschik, Dominik Wiedner, Johannes Herta, Jonathan Wais, Fabian Winter, Karl Roessler, Christian Dorfer

Summary: The use of non-steroidal anti-inflammatory drugs (NSAIDs) does not increase the recurrence rates of chronic subdural hematoma (cSDH), while male sex is identified as a risk factor for cSDH recurrence.

JOURNAL OF NEUROSURGICAL SCIENCES (2023)

Add to Collection

Review Oncology

Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer

Hannah Christina Puhr, Thorsten J. Reiter, Matthias Preusser, Gerald W. Prager, Ayseguel Ilhan-Mutlu

Summary: Gastroesophageal cancer is a devastating disease with poor survival outcomes. Advances in immunotherapy and targeted therapies are being explored to improve patient management and outcomes. This review summarizes the progress in these treatments for localized gastric, gastroesophageal junction, and esophageal tumors, as well as ongoing promising clinical trials.

CANCERS (2023)

Add to Collection

Article Oncology

Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study

Wolfgang Marik, Pedro Lima Cardoso, Elisabeth Springer, Wolfgang Bogner, Matthias Preusser, Georg Widhalm, Gilbert Hangel, Johannes A. Hainfellner, Ivo Rausch, Michael Weber, Victor Schmidbauer, Tatjana Traub-Weidinger, Siegfried Trattnig

Summary: Qualitative assessments are currently the main method for neuro-oncologic MRI, while PET provides important metabolic information. However, PET provides quantitative data while qualitative MRI is limited by subjective judgments and low inter-scanner reliability. MR fingerprinting is a promising approach that can generate both qualitative and quantitative imaging data based on a single sequence acquisition. This study compared PET and MR fingerprinting in predicting tumor-related characteristics and found that both modalities have high predictability but with different underlying mechanisms. The combined use of PET and MR fingerprinting shows potential to enhance tissue-specific properties and increase the value of hybrid imaging in neuro-oncology.

CANCERS (2023)

Add to Collection

Article Oncology

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma

Hannah C. Puhr, Clemens C. Weirauch, Flora Selimi, Karin Oberreiter, Martin A. Dieterle, Gerd Jomrich, Sebastian F. Schoppmann, Gerald W. Prager, Anna S. Berghoff, Matthias Preusser, Aysegul Ilhan-Mutlu

Summary: This study analyzed systemic inflammatory biomarkers in patients with gastroesophageal adenocarcinoma and found that modified Glasgow Prognostic Score was associated with patients' survival.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups

Olga Ciobanu-Caraus, Thomas Czech, Andreas Peyrl, Christine Haberler, Gregor Kasprian, Julia Furtner, Marcel Kool, Martin Sill, Josa M. Frischer, Anna Cho, Irene Slavc, Karl Roessler, Johannes Gojo, Christian Dorfer

Summary: This study investigated the correlation between intraoperative observation of the site of origin and molecular subtypes of medulloblastoma (MB). The results showed that intraoperative observation had limited predictive value for determining the molecular subtype. Therefore, maximal safe resection should remain the aim of surgery.

CANCERS (2023)

Add to Collection

Article Clinical Neurology

Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative

Emilie Le Rhun, Florien Boele, Giuseppe Minniti, Norbert Galldiks, Martin Taphoorn, Karin Piil, Roberta Ruda, Simone P. Niclou, Marjolein Geurts, Matthias Preusser, Michael Weller, Susan C. Short, Linda Dirven

Summary: As the proportion of women in neuro-oncology healthcare and biomedical research professionals continues to grow, promoting gender equality becomes increasingly important. The results of the survey showed that the majority of participants believed that positive action is needed to enhance the role of women in this field and favored prioritizing women to achieve gender balance. Additionally, indicators such as salary, paid overtime, number of permanent positions, protected time for research, and training opportunities were considered important in measuring gender balance.

NEURO-ONCOLOGY PRACTICE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.